Table 1.
The clinicopathological relevance analysis of STK39 expression in patients with cholangiocarcinoma
| Characteristics | Low group |
High group |
P value |
|---|---|---|---|
| (N = 31) | (N = 31) | ||
| Gender | |||
| Male | 16 | 19 | 0.442 |
| Female | 15 | 12 | |
| Age (years) | |||
| <55 | 10 | 13 | 0.430 |
| ≥55 | 21 | 18 | |
| Tumor multiplicity | |||
| Single | 19 | 16 | 0.304 |
| Multiple | 12 | 15 | |
| Differentiation | |||
| Well to moderate | 20 | 14 | 0.126 |
| Poor | 11 | 17 | |
| Diameter (cm) | |||
| ≤5 | 17 | 9 | 0.035∗ |
| >5 | 14 | 22 | |
| TNM stage | |||
| I + II | 19 | 11 | 0.037∗ |
| III + IV | 12 | 20 | |
| Vascular invasion | |||
| Negative | 24 | 27 | 0.319 |
| Positive | 7 | 4 | |
| Microvascular invasion | |||
| Negative | 21 | 15 | 0.123 |
| Positive | 10 | 16 | |
| Lymph node metastasis | |||
| Negative | 22 | 12 | 0.011∗ |
| Positive | 9 | 19 | |
Annotation: ∗p<0.05.